Breakthrough nasal spray tested for rapid relief in teens with severe depression and suicidal thoughts
NCT ID NCT07227454
Summary
This study is testing whether a nasal spray called esketamine, when added to standard mental health care, can quickly reduce severe depression and suicidal thoughts in teenagers. It will compare the spray to a placebo (a look-alike treatment with no active drug) in about 258 teens who are experiencing an acute mental health crisis. The main goal is to see if the treatment leads to a significant improvement in depression symptoms within 24 hours.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, MAJOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peachford Hospital-Atlanta Behavioral Research
RECRUITINGAtlanta, Georgia, 30338, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45219, United States
Conditions
Explore the condition pages connected to this study.